Knuff & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.54M | Hold |
63,859
| – | – | 0.39% | 46 |
|
|
2026
Q1 | $1.79M | Hold |
63,859
| – | – | 0.54% | 40 |
|
|
2025
Q4 | $1.59M | Hold |
63,859
| – | – | 0.47% | 41 |
|
|
2025
Q3 | $1.63M | Sell |
63,859
-71
| -0.1% | -$1.75K | 0.47% | 41 |
|
|
2025
Q2 | $1.55M | Buy |
63,930
+71
| +0.1% | +$1.66K | 0.49% | 38 |
|
|
2025
Q1 | $1.62M | Sell |
63,859
-699
| -1% | -$18.3K | 0.54% | 37 |
|
|
2024
Q4 | $1.71M | Hold |
64,558
| – | – | 0.52% | 40 |
|
|
2024
Q3 | $1.87M | Sell |
64,558
-201
| -0.3% | -$5.86K | 0.57% | 41 |
|
|
2024
Q2 | $1.81M | Sell |
64,759
-800
| -1% | -$22K | 0.59% | 41 |
|
|
2024
Q1 | $1.82M | Hold |
65,559
| – | – | 0.61% | 42 |
|
|
2023
Q4 | $1.89M | Sell |
65,559
-640
| -1% | -$19.3K | 0.69% | 39 |
|
|
2023
Q3 | $2.2M | Sell |
66,199
-3,667
| -5% | -$130K | 0.88% | 33 |
|
|
2023
Q2 | $2.56M | Buy |
69,866
+2,977
| +4% | +$116K | 0.96% | 31 |
|
|
2023
Q1 | $2.73M | Sell |
66,889
-243
| -0.4% | -$10.5K | 1.08% | 29 |
|
|
2022
Q4 | $3.44M | Sell |
67,132
-45
| -0.1% | -$2.16K | 1.47% | 23 |
|
|
2022
Q3 | $2.94M | Hold |
67,177
| – | – | 1.39% | 22 |
|
|
2022
Q2 | $3.52M | Sell |
67,177
-20
| -0% | -$1.02K | 1.58% | 19 |
|
|
2022
Q1 | $3.48M | Sell |
67,197
-32,141
| -32% | -$1.67M | 1.26% | 23 |
|
|
2021
Q4 | $5.87M | Sell |
99,338
-625
| -0.6% | -$31K | 1.82% | 15 |
|
|
2021
Q3 | $4.3M | Hold |
99,963
| – | – | 1.61% | 22 |
|
|
2021
Q2 | $3.92M | Sell |
99,963
-25
| -0% | -$972 | 1.45% | 25 |
|
|
2021
Q1 | $3.62M | Hold |
99,988
| – | – | 1.55% | 23 |
|
|
2020
Q4 | $3.68M | Sell |
99,988
-7,961
| -7% | -$292K | 1.52% | 25 |
|
|
2020
Q3 | $3.76M | Buy |
107,949
+3,015
| +3% | +$106K | 1.77% | 16 |
|
|
2020
Q2 | $3.26M | Buy |
104,934
+2,740
| +3% | +$93.1K | 1.78% | 17 |
|
|
2020
Q1 | $3.17M | Sell |
102,194
-1,581
| -2% | -$53.9K | 2.3% | 11 |
|
|
2019
Q4 | $3.86M | Buy |
103,775
+782
| +0.8% | +$27.9K | 2.31% | 11 |
|
|
2019
Q3 | $3.51M | Hold |
102,993
| – | – | 2.41% | 11 |
|
|
2019
Q2 | $4.23M | Sell |
102,993
-737
| -0.7% | -$29.3K | 3.01% | 9 |
|
|
2019
Q1 | $4.18M | Buy |
103,730
+737
| +0.7% | +$29.5K | 3.21% | 7 |
|
|
2018
Q4 | $4.26M | Buy |
+102,993
| New | +$4.28M | 4.19% | 6 |
|
Other funds holding PFE
Knuff & Co's PFE Position: Q2 2026 in Review
Knuff & Co held its Pfizer (PFE) position steady in Q2 2026 at 63,859 shares worth $1.54M. The position accounts for 0.39% of the portfolio, ranked #46.
Knuff & Co first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $5.87M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Knuff & Co held 63,859 shares of Pfizer worth $1.54M as of Q2 2026.
- Knuff & Co left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.39% of Knuff & Co's portfolio in Q2 2026, its #46 holding.
- Knuff & Co first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Knuff & Co's Pfizer position peaked at $5.87M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Knuff & Co's 13F filing for Q2 2026, filed 10 Aug 2026.